Package 69539-112-01

Brand: azacitidine

Generic: azacitidine
NDC Package

Package Facts

Identity

Package NDC 69539-112-01
Digits Only 6953911201
Product NDC 69539-112
Product ID 69539-112_149556cf-d002-4d8b-875b-062561da3f44
Description

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (69539-112-01)

Marketing

Marketing Status
Marketed Since 2024-05-18
Brand azacitidine
Generic azacitidine
Sample Package No

Linked Drug Pages (1)

Azacitidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "149556cf-d002-4d8b-875b-062561da3f44", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0369539112012"], "unii": ["M801H13NRU"], "rxcui": ["485246"], "spl_set_id": ["d24f1fc5-17c6-4e0c-b852-72692e835cff"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["MSN LABORATORIES PRIVATE LIMITED"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (69539-112-01)", "package_ndc": "69539-112-01", "marketing_start_date": "20240518"}], "brand_name": "Azacitidine", "product_id": "69539-112_149556cf-d002-4d8b-875b-062561da3f44", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "69539-112", "generic_name": "Azacitidine", "labeler_name": "MSN LABORATORIES PRIVATE LIMITED", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azacitidine", "active_ingredients": [{"name": "AZACITIDINE", "strength": "100 mg/1"}], "application_number": "ANDA212580", "marketing_category": "ANDA", "marketing_start_date": "20240516", "listing_expiration_date": "20261231"}